NCT07832825Not yet recruiting
Effect of Body Mass Index on ICSI Outcomes
Effect of Body Mass Index on Intracytoplasmic Sperm Injection Cycles
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
This retrospective cohort study aims to evaluate the effect of body mass index on the outcomes of intracytoplasmic sperm injection (ICSI) cycles at Assiut Women Health Hospital.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 350 (estimated)
- First submitted
- 16 Sept 2026
- Start date
- 20 Sept 2026
- Primary completion date
- 20 Sept 2027
- Lead sponsor
- Assiut University
- Diseases
- Obesity
- NCT number
- NCT07832825
What you commit to
- Study type: Observational
- Planned participants: 350
- From 20 Sept 2026 to the primary completion date, 20 Sept 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Cases with no recorded weight or height at registration
Who the study is looking for
- Women who underwent ICSI cycles at Assiut Women Health Hospital
- Recorded weight and height at the start of treatment
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.